SOCS1

SOCS1, also known as STAT-induced STAT inhibitor or JAK-binding protein, is a member of the SOCS family of proteins. It functions as a negative regulator of the JAK-STAT signaling pathway, inhibiting the activation of JAK2 kinase and thus modulating cytokine signaling. SOCS1 plays a crucial role in immune cell responses and tumor suppression. It is involved in the regulation of various inflammatory cytokines and T cell homeostasis. Deficiency or dysregulation of SOCS1 has been associated with autoimmunity, cancer, and inflammation-related diseases. Recent research has focused on the development of drugs targeting SOCS1 for the treatment of these conditions, including inhibitors of DNMT1, which can reverse the hypermethylation of the SOCS1 promoter and restore its expression.